(Q73867294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

title

The continuing evolution of the drug discovery process in the pharmaceutical industry (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

E Ratti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Trist

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 January 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Il Farmaco

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

56

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

13-19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

Definition and antagonism of histamine H 2 -receptors

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2801%2901019-9

Design of potent, orally effective, nonpeptidal antagonists of the peptide hormone cholecystokinin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2801%2901019-9

Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2801%2901019-9

Apolipoprotein E and Alzheimer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2801%2901019-9

Pharmaceutical innovation by the seven UK-owned pharmaceutical companies (1964-1985)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-827X%2801%2901019-9

10.1016/S0014-827X(01)01019-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11347954%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference